Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
000963:SHE
Huadong Medicine Co., Ltd.
CNÂ¥35.18
+3.20%
(+1.09) 1D
Apr 24, 3:04:36 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000963...
Open
CNÂ¥34.35
High
CNÂ¥35.59
Low
CNÂ¥34.19
Mkt. cap
61.70B
Avg. vol.
10.78M
Volume
23.82M
Dividend
2.64%
Quarterly dividend
CNÂ¥0.23
Ex dividend date
Jun 5, 2025
P/E ratio
16.71
52-wk high
CNÂ¥47.36
52-wk low
CNÂ¥33.10
EPS
CNÂ¥2.11
Shares outstanding
1.75B
No. of employees
18K
News stories
From sources across the web
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees18.3K
FoundedMar 31, 1993
Headquarters-
SectorHealth care provider
Websiteeastchinapharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.94B
10.99B
10.95B
11.18B
Cost of goods sold
7.12B
7.39B
7.78B
7.39B
Cost of revenue
7.12B
7.39B
7.78B
7.39B
Research and development expenses
484.30M
507.92M
245.56M
350.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.13B
1.93B
1.99B
2.19B
Operating expense
2.75B
2.33B
2.16B
2.58B
Total operating expenses
9.87B
9.72B
9.94B
9.97B
Operating income
1.07B
1.27B
1.01B
1.22B
Other non operating income
31.05M
-72.31M
-162.04M
-3.11M
EBT including unusual items
1.09B
1.07B
753.84M
1.19B
EBT excluding unusual items
1.09B
1.19B
859.77M
1.21B
Income tax expense
198.87M
130.93M
84.85M
195.03M
Effective tax rate
18.27%
12.24%
11.26%
16.36%
Other operating expenses
54.16M
-105.72M
5.97M
36.54M
Net income
900.12M
933.09M
666.42M
1.00B
Net profit margin
8.23%
8.49%
6.09%
8.96%
Earnings per share
0.49
0.54
-
-
Interest and investment income
17.80M
26.71M
86.55M
-
Interest expense
-26.92M
-33.70M
-
-
Net interest expenses
-9.12M
-6.99M
14.22M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
1.32B
1.46B
1.24B
1.45B
Gain or loss from assets sale
6.20M
-6.20M
-2.26M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer